Madrigal Pharmaceuticals
MDGL
#1759
Rank
HK$93.32 B
Marketcap
HK$4,068
Share price
-0.89%
Change (1 day)
62.76%
Change (1 year)

Revenue for Madrigal Pharmaceuticals (MDGL)

Revenue in 2025 (TTM): HK$7.47 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is HK$7.50 Billion. an increase over the revenue in the year 2024 that were of HK$1.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Madrigal Pharmaceuticals from 2008 to 2025

Annual revenue

Year Revenue Change
2025 HK$7.45 B433.23%
2024 HK$1.39 B
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A-100%
2012 HK$1.13 M-98.07%
2011 HK$58.9 M-48.87%
2010 HK$0.11 B-89.7%
2009 HK$1.11 B3057.37%
2008 HK$35.42 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
HK$5.02 B-33.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
HK$1.76 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA